Published 8 days ago • loading... • Updated 8 days ago

Laverdia-CA1's field trial ends, statistical analysis to begin

Summary by dvm360.com

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All

Left

Center

Right

dvm360.com

Laverdia-CA1's field trial ends, statistical analysis to begin

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

Anivive Announces Completion of LAVERDIA®-CA1 Pivotal Field Study for Canine Lymphoma

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studiesEffectiveness data will soon be finalized for statistical review and FDA submission

8 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year